Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast. 2018

Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, Quebec City, QC, Canada.

OBJECTIVE Pure tubular carcinomas (TC) of the breast are generally considered to have an excellent prognosis. This study aimed to analyze the characteristics and survival of patients with TC. METHODS This was a retrospective study conducted at the CHU de Québec-Université Laval. Databases were searched for all cases treated between April 1997 and December 2010. Survival was retrieved from the Province of Quebec Ministry of Health. Follow-up was censored on December 31, 2011. Overall survival (OS) was compared to patients with invasive ductal carcinoma (ICD) matched for age, tumor size, lymph node involvement, year of diagnosis, ER, PgR, and HER2, histological grade, lymphovascular invasion, and chemotherapy. RESULTS The frequency of TC was 2.9% (n = 223/7563). Tumors size was 7.4 ± 8.8 mm, without lymphovascular invasion (95.1%), ER-positive (98.2%), PgR-positive (69.5%), and HER2-negative (100%). Patients were followed up for 7.1 ± 2.7 years. The actuarial 13-year OS was 89.0% for TC, compared to 85.8% for IDC (P = 0.13). For TC, the 13-year OS was 95.8% in NO patients compared to 90.0% for N1-3 (P = 0.01). CONCLUSIONS Despite the general popular belief that patients with TC fare better than patients with IDC, the 13-year OS of TC was similar to that of grade I IDC.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
June 2018, Journal of surgical oncology,
Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
April 2023, European journal of breast health,
Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
June 2013, World journal of surgical oncology,
Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
March 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
March 1985, Histopathology,
Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
October 1991, Surgery, gynecology & obstetrics,
Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
May 1987, Lancet (London, England),
Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
January 2021, Technology in cancer research & treatment,
Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
September 2012, International journal of radiation oncology, biology, physics,
Éric Poirier, and Christine Desbiens, and Brigitte Poirier, and Dominique Boudreau, and Simon Jacob, and Julie Lemieux, and Catherine Doyle, and Caroline Diorio, and Jean-Charles Hogue, and Louise Provencher
June 2023, Journal of medical case reports,
Copied contents to your clipboard!